Literature DB >> 17894369

The influence of drug morphology on aerosolisation efficiency of dry powder inhaler formulations.

Handoko Adi1, Daniela Traini, Hak-Kim Chan, Paul M Young.   

Abstract

The physicochemical properties of two forms of spray dried bovine serum albumin (BSA) have been investigated using particle sizing, surface energy measurement, atomic force microscopy (AFM) and colloid probe microscopy. The BSA powder had similar particle size distributions and surface energy but significantly different morphologies and roughness, classified as smooth and corrugated BSA. Adhesion forces between the corrugated BSA and alpha-lactose monohydrate indicated median adhesion forces were significantly less than for smooth/carrier interaction forces. These observations correlated well with aerosolisation from BSA/carrier blends, where the corrugated BSA particles gave a higher fine particle fraction than the smooth BSA, suggesting reduced BSA/carrier adhesion and increased drug liberation. The use of corrugated drug particle morphology in drug carrier DPI systems may lead to improved aerosol performance through reduced drug carrier contact area.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17894369     DOI: 10.1002/jps.21195

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  18 in total

1.  Preparation and in vitro aerosol performance of spray-dried Shuang-Huang-Lian corrugated particles in carrier-based dry powder inhalers.

Authors:  Jing-Jing Yang; Chun-Yu Liu; Li-Hui Quan; Yong-Hong Liao
Journal:  AAPS PharmSciTech       Date:  2012-05-30       Impact factor: 3.246

2.  Formation of protein nano-matrix particles with controlled surface architecture for respiratory drug delivery.

Authors:  Philip Chi Lip Kwok; Amolnat Tunsirikongkon; William Glover; Hak-Kim Chan
Journal:  Pharm Res       Date:  2010-12-07       Impact factor: 4.200

3.  Effect of Device Design and Formulation on the In Vitro Comparability for Multi-Unit Dose Dry Powder Inhalers.

Authors:  Jagdeep Shur; Bhawana Saluja; Sau Lee; James Tibbatts; Robert Price
Journal:  AAPS J       Date:  2015-05-09       Impact factor: 4.009

4.  The contribution of different formulation components on the aerosol charge in carrier-based dry powder inhaler systems.

Authors:  Susan Hoe; Daniela Traini; Hak-Kim Chan; Paul M Young
Journal:  Pharm Res       Date:  2010-03-31       Impact factor: 4.200

5.  Engineering of crystalline combination inhalation particles of a long-acting beta2-agonist and a corticosteroid.

Authors:  Chonladda Pitchayajittipong; Jagdeep Shur; Robert Price
Journal:  Pharm Res       Date:  2009-09-26       Impact factor: 4.200

6.  Effect of surface coating with magnesium stearate via mechanical dry powder coating approach on the aerosol performance of micronized drug powders from dry powder inhalers.

Authors:  Qi Tony Zhou; Li Qu; Thomas Gengenbach; Ian Larson; Peter J Stewart; David A V Morton
Journal:  AAPS PharmSciTech       Date:  2012-11-30       Impact factor: 3.246

7.  Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers.

Authors:  Xiaojian Li; Frederick G Vogt; Don Hayes; Heidi M Mansour
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2014-02-06       Impact factor: 2.849

8.  Physicochemical characterization and water vapor sorption of organic solution advanced spray-dried inhalable trehalose microparticles and nanoparticles for targeted dry powder pulmonary inhalation delivery.

Authors:  Xiaojian Li; Heidi M Mansour
Journal:  AAPS PharmSciTech       Date:  2011-10-25       Impact factor: 3.246

Review 9.  Physical stability of dry powder inhaler formulations.

Authors:  Nivedita Shetty; David Cipolla; Heejun Park; Qi Tony Zhou
Journal:  Expert Opin Drug Deliv       Date:  2019-12-13       Impact factor: 6.648

10.  Evaluation of granulated lactose as a carrier for DPI formulations 1: effect of granule size.

Authors:  Ping Du; Ju Du; Hugh D C Smyth
Journal:  AAPS PharmSciTech       Date:  2014-06-25       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.